On December 17, 2009, Los Angeles Superior Court Judge Peter D. Litchman certified a UCL deceptive advertising class in
Johnson v. GlaxoSmithKline arising out the promotion of the drug Paxil. This case is one which my firm filed way back in 2003, and has seen many ups and downs, including outright dismissal.
See Johnson v. GlaxoSmithKline, Inc., 166 Cal. App. 4th 1497 (2008). As I am a directly involved in this case, I will leave my statements on this matter at that. However, I would like to say that certification of was achieved by a great group of attorneys, not only from my office, but from Milstein, Adelman & Kreger, LLP and Kabateck Brown and Kellner.
0 comments:
Post a Comment